Skip to Content
Stock Strategist

Our Outlook for the Health-Care Sector

Political and regulatory changes could sway biotech and drug stocks.

Mentioned: , , , , , , , , ,

<< Return to Main Market Outlook Page

Compared with other industries, health care is more vulnerable to external forces including political and regulatory actions. We have recently seen a few potential changes on the horizon that could blow a cool wind over pharmaceutical, biotech, and medical device companies.

Debbie Wang has a position in the following securities mentioned above: NVS, PFE, VTRS. Find out about Morningstar’s editorial policies.